Targeting Omc-B of Chlamydia trachomatis for the Blinding Infection Trachoma using Phytochemicals from Calpurnia aurea and Abrus precatorius

Blinding trachoma called trichiasis is the eye infection caused by the obligate bacterium Chlamydia trachomatis,
which triggers the inflammatory process in the conjunctiva mucosa and is believed to be the prime step towards
the development of scarring. Reoccurrence of infection lead the eyelids to turn inward which ultimately scar the
cornea through the continuous scrape caused by eyelashes. Like leprosy, Guinea worm, lymphatic filariasis,
onchocerciasis, etc, trachoma is one of the neglected tropical disease, although 540 million people are reported at
risk in 55 countries and 84 million are already infected. Trachoma, being the eighth commonest blinding disease
overall the world, become global burden in terms of both disability it causes and the economic costs. The World
Health Organization (WHO) assembly led an alliance GET2020 (Alliance for Global Elimination of Blinding
Trachoma by 2020), in order to eliminate the blinding trachoma by the year 2020, which in adoption by SAFE
strategy actively participates based on four different components like surgery for trichiasis, antibiotics for
infection, facial cleanliness and avail criteria to improve environmental factors to reduce transmission.
Zithromax, an antibiotic is used for treating the infection, has a lot more side effects and the effect on recurrence
is also uncertain. With the recent development in the field of science and technology, the present study utilizing
the bioinformatics tools and software, aims at identifying a novel inhibitor from the plant source for the targets
that involve in the pathogenicity of the organism